QUOTED. 22 November 2019. Daniel McBride.
The US FDA has approved CooperVision Inc.’s MiSight, the first contact lens that can help slow the progression of nearsightedness (myopia) in children. See what CooperVision president Daniel McBride said about it here.
“We can’t overstate the importance and potential impact of this landmark decision on children’s vision, especially considering the rise in myopia’s severity and prevalence in the US and worldwide. Eye-care professionals who embrace this breakthrough approach will improve the quality of life and eye health for so many children.” – Daniel McBride, president, CooperVision Inc.
- Find out more: CooperVision Nabs Approval On Pediatric Contact Lens
Click here for a free trial of Medtech Insight